148 related articles for article (PubMed ID: 27036037)
1. Age related increase in mTOR activity contributes to the pathological changes in ovarian surface epithelium.
Bajwa P; Nagendra PB; Nielsen S; Sahoo SS; Bielanowicz A; Lombard JM; Wilkinson JE; Miller RA; Tanwar PS
Oncotarget; 2016 Apr; 7(15):19214-27. PubMed ID: 27036037
[TBL] [Abstract][Full Text] [Related]
2. Overactive mTOR signaling leads to endometrial hyperplasia in aged women and mice.
Bajwa P; Nielsen S; Lombard JM; Rassam L; Nahar P; Rueda BR; Wilkinson JE; Miller RA; Tanwar PS
Oncotarget; 2017 Jan; 8(5):7265-7275. PubMed ID: 27980219
[TBL] [Abstract][Full Text] [Related]
3. Early transformative changes in normal ovarian surface epithelium induced by oxidative stress require Akt upregulation, DNA damage and epithelial-stromal interaction.
King SM; Quartuccio SM; Vanderhyden BC; Burdette JE
Carcinogenesis; 2013 May; 34(5):1125-33. PubMed ID: 23299406
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological targeting of mammalian target of rapamycin inhibits ovarian granulosa cell tumor growth.
Rico C; Laguë MN; Lefèvre P; Tsoi M; Dodelet-Devillers A; Kumar V; Lapointe E; Paquet M; Nadeau MÈ; Boerboom D
Carcinogenesis; 2012 Nov; 33(11):2283-92. PubMed ID: 22871496
[TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN.
Tanwar PS; Zhang L; Kaneko-Tarui T; Curley MD; Taketo MM; Rani P; Roberts DJ; Teixeira JM
PLoS One; 2011; 6(6):e20715. PubMed ID: 21695255
[TBL] [Abstract][Full Text] [Related]
6. FSH-FSHR3-stem cells in ovary surface epithelium: basis for adult ovarian biology, failure, aging, and cancer.
Bhartiya D; Singh J
Reproduction; 2015 Jan; 149(1):R35-48. PubMed ID: 25269615
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of TRP53, PTEN, RB1, and/or CDH1 in the ovarian surface epithelium induces ovarian cancer transformation and metastasis.
Shi M; Whorton AE; Sekulovski N; Paquet M; MacLean JA; Song Y; Van Dyke T; Hayashi K
Biol Reprod; 2020 Apr; 102(5):1055-1064. PubMed ID: 31930396
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of pluripotent and germ cell markers in ovarian surface epithelium according to age in female mice.
Joo BS; Jung IK; Park MJ; Joo JK; Kim KH; Lee KS
Reprod Biol Endocrinol; 2014 Nov; 12():113. PubMed ID: 25421381
[TBL] [Abstract][Full Text] [Related]
9. Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.
Clark-Knowles KV; Garson K; Jonkers J; Vanderhyden BC
Exp Cell Res; 2007 Jan; 313(1):133-45. PubMed ID: 17070800
[TBL] [Abstract][Full Text] [Related]
10. Repeat estradiol exposure differentially regulates protein expression patterns for estrogen receptor and E-cadherin in older mouse ovarian surface epithelium: implications for replacement and adjuvant hormone therapies?
Gulliver LS; Hurst PR
Steroids; 2012 May; 77(6):674-85. PubMed ID: 22406420
[TBL] [Abstract][Full Text] [Related]
11. [Expression relationship of Hippo signaling molecules and ovarian germline stem cell markers in the ovarian aging process of women and mice].
Xu J; Cao XP; Tang ZJ; Huang J; Zheng YH; Li J
Sheng Li Xue Bao; 2019 Jun; 71(3):405-414. PubMed ID: 31218331
[TBL] [Abstract][Full Text] [Related]
12. Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.
Tanwar PS; Mohapatra G; Chiang S; Engler DA; Zhang L; Kaneko-Tarui T; Ohguchi Y; Birrer MJ; Teixeira JM
Carcinogenesis; 2014 Mar; 35(3):546-53. PubMed ID: 24170201
[TBL] [Abstract][Full Text] [Related]
13. Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis.
Zhang Y; Vasheghani F; Li YH; Blati M; Simeone K; Fahmi H; Lussier B; Roughley P; Lagares D; Pelletier JP; Martel-Pelletier J; Kapoor M
Ann Rheum Dis; 2015 Jul; 74(7):1432-40. PubMed ID: 24651621
[TBL] [Abstract][Full Text] [Related]
14. Comparative idiosyncrasies in life extension by reduced mTOR signalling and its distinctiveness from dietary restriction.
Garratt M; Nakagawa S; Simons MJ
Aging Cell; 2016 Aug; 15(4):737-43. PubMed ID: 27139919
[TBL] [Abstract][Full Text] [Related]
15. Induction of proliferation in the primate ovarian surface epithelium in vivo.
Wright JW; Pejovic T; Fanton J; Stouffer RL
Hum Reprod; 2008 Jan; 23(1):129-38. PubMed ID: 18000169
[TBL] [Abstract][Full Text] [Related]
16. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
[TBL] [Abstract][Full Text] [Related]
17. Promotion of ovarian follicle growth following mTOR activation: synergistic effects of AKT stimulators.
Cheng Y; Kim J; Li XX; Hsueh AJ
PLoS One; 2015; 10(2):e0117769. PubMed ID: 25710488
[TBL] [Abstract][Full Text] [Related]
18. Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium.
Wong AS; Kim SO; Leung PC; Auersperg N; Pelech SL
Gynecol Oncol; 2001 Aug; 82(2):305-11. PubMed ID: 11531284
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun.
Itamochi H; Oishi T; Shimada M; Sato S; Uegaki K; Naniwa J; Sato S; Nonaka M; Terakawa N; Kigawa J; Harada T
Clin Cancer Res; 2011 Jul; 17(14):4742-50. PubMed ID: 21610153
[TBL] [Abstract][Full Text] [Related]
20. The role of mTOR in ovarian Neoplasms, polycystic ovary syndrome, and ovarian aging.
Liu J; Wu DC; Qu LH; Liao HQ; Li MX
Clin Anat; 2018 Sep; 31(6):891-898. PubMed ID: 29752839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
